aim
aim
studi
describ
frequenc
viral
pathogen
rel
frequenc
coinfect
nasal
specimen
obtain
young
children
bronchiol
receiv
care
children
hospit
method
conduct
studi
nasal
wash
specimen
use
realtim
pcr
fluorescentantibodi
assay
result
children
less
two
code
bronchiol
specimen
collect
clinic
care
children
hospit
seattl
wa
usa
respiratori
season
octob
april
result
virus
detect
children
bronchiol
singl
viru
identifi
children
multipl
virus
respiratori
syncyti
viru
rsv
common
viru
detect
follow
adenoviru
human
metapneumoviru
coronaviru
parainfluenza
influenza
sampl
rsv
detect
coinfect
anoth
viral
pathogen
conclus
molecular
diagnost
techniqu
identifi
high
frequenc
virus
viral
coinfect
among
children
evalu
bronchiol
studi
role
viral
pathogen
rsv
coinfect
rsv
children
bronchiol
appear
warrant
bronchiol
common
caus
infecti
diseas
hospit
among
infant
unit
state
approxim
children
age
year
hospit
annual
bronchiol
cost
hospit
estim
exceed
million
although
bronchiol
common
diseas
readili
diagnos
clinic
standard
practic
diagnosi
manag
bronchiol
still
sourc
debat
address
concern
american
academi
pediatr
aap
develop
publish
clinic
practic
guidelin
guidelin
recommend
diagnosi
base
histori
physic
examin
discourag
virolog
test
basi
result
rare
impact
manag
decis
guidelin
state
howev
virolog
test
may
use
patient
cohort
possibl
respiratori
syncyti
viru
rsv
predomin
viru
classic
associ
bronchiol
report
studi
reli
cultur
serolog
detect
method
rsv
detect
case
bronchiol
parainfluenza
piv
adenoviru
influenza
commonli
detect
virus
develop
abbrevi
aap
american
associ
pediatr
pcr
polymeras
chain
reaction
fa
fluoresc
antibodi
rsv
respiratori
syncyti
viru
piv
parainfluenza
hmpv
human
metapneumoviru
rv
rhinoviru
sensit
diagnost
method
polymeras
chain
reaction
assay
pcr
increas
number
virus
eg
human
metapnuemoviru
detect
children
acut
respiratori
tract
infect
previou
studi
respiratori
virus
children
use
molecular
diagnost
focus
children
spectrum
respiratori
tract
infect
associ
acut
wheez
populationbas
studi
children
bronchiol
use
molecular
diagnost
object
studi
determin
rel
frequenc
variou
viral
pathogen
frequenc
viral
coinfect
children
less
year
bronchiol
present
acut
care
hospit
set
studi
approv
institut
review
board
children
hospit
region
medic
center
seattl
wa
usa
residu
clinic
nasal
wash
sampl
collect
children
age
present
respiratori
symptom
emerg
depart
inpati
children
hospit
region
medic
center
seattl
washington
octob
april
octob
april
encompass
period
greatest
respiratori
viru
activ
region
total
nasal
wash
sampl
suffici
residu
materi
avail
test
realtim
pcr
previous
publish
current
studi
includ
subset
sampl
specif
obtain
patient
less
month
percentag
reflect
pathogen
detect
within
specif
age
group
total
exceed
coinfect
age
bronchiol
bill
record
obtain
patient
residu
nasal
wash
sampl
bronchiol
defin
intern
classif
diseas
ninth
revis
clinic
modif
code
bronchiol
base
definit
infant
less
month
age
includ
studi
popul
elig
patient
contribut
one
sampl
analysi
singl
child
multipl
hospit
visit
andor
sampl
earliest
sampl
select
analysi
clinic
data
abstract
medic
record
use
standard
form
demograph
inform
includ
age
gender
underli
diseas
condit
record
rapid
viral
test
conduct
clinic
care
use
indirect
fluorescentantibodi
fa
assay
test
rsv
piv
type
adenoviru
influenza
b
fa
assay
avail
human
metapneumoviru
hmpv
coronaviru
studi
patient
respiratori
sampl
later
analys
multiplex
realtim
pcr
without
prior
knowledg
fa
result
follow
virus
rsv
adenoviru
hmpv
coronaviru
piv
type
influenza
pcr
perform
total
nucleic
acid
isol
frozen
nasal
wash
sampl
use
previous
describ
onestep
reversetranscript
pcr
master
mix
rna
virus
master
mix
adenoviru
dna
primer
probe
sequenc
design
use
primer
express
softwar
appli
biosystem
foster
citi
ca
usa
previous
describ
prior
studi
indic
fa
realtim
pcr
viral
test
strongli
correl
rsv
influenza
pcr
sensit
fa
piv
adenoviru
statist
analys
perform
use
stata
colleg
station
tx
usa
percent
averag
median
rang
calcul
demograph
variabl
virolog
test
result
singl
nasal
wash
sampl
children
month
age
diagnosi
bronchiol
collect
octob
april
fiftyf
percent
studi
subject
male
median
age
month
rang
month
major
children
admit
gener
pediatr
ward
children
intens
care
unit
children
thirtynin
children
evalu
emerg
depart
discharg
home
averag
children
respiratori
symptom
day
prior
sampl
collect
thirtyseven
children
least
one
follow
chronic
diseas
condit
asthma
n
cardiac
condit
n
pulmonari
condit
n
renal
condit
n
malign
n
gastrointestin
condit
n
neurolog
condit
n
realtim
pcr
fa
detect
method
detect
one
respiratori
virus
patient
singl
viru
detect
children
multipl
virus
detect
children
rsv
detect
children
adenoviru
hmpv
coronaviru
piv
influenza
tabl
children
multipl
virus
detect
rsv
common
pathogen
follow
adenoviru
coronaviru
tabl
viru
rsv
either
alon
combin
anoth
viru
detect
children
children
rsv
detect
fa
andor
realtim
pcr
children
one
addit
pathogen
identifi
rsv
coinfect
occur
frequent
adenoviru
sampl
follow
coronaviru
sampl
hmpv
sampl
piv
sampl
influenza
sampl
one
specimen
contain
three
respiratori
virus
rsv
hmpv
adenoviru
contribut
month
old
evalu
emerg
depart
respiratori
distress
seven
coinfect
occur
absenc
rsv
tabl
demonstr
high
rate
respiratori
viru
detect
use
sensit
molecularbas
assay
among
larg
sampl
children
evalu
bronchiol
hospit
set
detect
least
one
viru
children
clinic
diagnosi
bronchiol
rsv
common
pathogen
detect
children
viru
rsv
detect
children
coinfect
occur
children
develop
sensit
molecular
diagnost
assay
increas
number
virus
detect
comparison
convent
method
previou
studi
analys
viral
detect
capac
cultur
direct
immunofluoresc
multiplex
pcr
children
acut
respiratori
ill
found
pcr
sensit
method
children
viru
detect
nasal
sampl
anoth
studi
infant
acut
lower
respiratori
tract
infect
perform
pcr
nasopharyng
aspir
detect
virus
patient
studi
found
rsv
first
second
commonli
detect
viru
rhinoviru
rv
second
first
frequent
viru
respect
studi
demonstr
similarli
high
frequenc
rsv
follow
adenoviru
hmpv
test
rv
use
molecular
techniqu
viral
detect
increas
identif
multipl
virus
singl
sampl
preval
coinfect
studi
rang
young
children
divers
type
respiratori
tract
infect
seen
hospit
emerg
depart
publish
studi
use
molecular
diagnost
report
coinfect
children
bronchiol
analys
children
diagnos
entir
respiratori
season
studi
ong
et
al
infant
rsv
bronchiol
hospit
onemonth
period
identifi
dual
infect
patient
studi
greensil
et
al
infant
bronchiol
requir
mechan
ventil
report
coinfect
rate
among
hmpv
rsv
coinfect
rate
report
mansbach
et
al
multicentr
studi
sampl
children
bronchiol
two
threeweek
period
one
previou
studi
populationbas
repres
full
viral
respiratori
season
studi
set
greec
includ
infant
less
year
age
bronchiol
coinfect
detect
children
dual
infect
rsv
rv
studi
identifi
coinfect
children
bronchiol
despit
test
rv
contrast
studi
ong
greensil
studi
popul
larger
encompass
entir
respiratori
season
compris
patient
discharg
emerg
depart
admit
gener
pediatr
floor
intens
care
unit
aap
guidelin
recommend
limit
laboratori
test
diseas
diagnosi
state
virolog
test
may
benefici
patient
cohort
feasibl
mani
facil
use
fa
test
direct
cohort
hall
lieberth
emphas
rapid
test
avail
typic
limit
rsv
influenza
perform
variabl
reliabl
use
sensit
assay
found
children
rsv
detect
infect
anoth
pathogen
pathogen
detect
well
current
fa
assay
interpret
copathogen
data
organ
coronaviru
adenoviru
problemat
due
difficulti
differenti
acut
diseas
longterm
shed
extent
bronchiol
may
caus
exacerb
virus
definit
establish
result
suggest
issu
viral
test
merit
investig
potenti
impact
patient
cohort
manag
algorithm
limit
studi
includ
retrospect
design
use
residu
clinic
sampl
addit
extend
studi
summer
month
potenti
decreas
detect
parainfluenza
viru
infect
although
test
wide
spectrum
virus
viral
detect
bocaviru
picornavirus
rhinoviru
includ
studi
due
limit
specimen
volum
despit
limit
identifi
one
virus
sampl
result
studi
confirm
previou
observ
rsv
frequent
detect
viru
patient
bronchiol
also
highlight
potenti
signific
viral
pathogen
hmpv
adenoviru
clinic
set
given
substanti
presenc
viral
coinfect
rsv
bronchiol
provid
need
recogn
potenti
limit
rapid
rsv
test
alon
cohort
purpos
data
underscor
studi
warrant
determin
clinic
impact
virus
rsv
children
bronchiol
